SIFI > About
Vision & History

Established in 1935 by two local pharmacists in Sicily, SIFI started as a venture, specializing in the preparation of ophthalmic products. Since then, research, development, innovation and production have never stopped. Today, SIFI has evolved into an industrial group of companies, consolidating domestic leadership and expanding into international markets worldwide.

A closer look …
SIFI is the only Italian ophthalmic company to feature an full-cycle, integrated business model, including research, development, manufacturing and marketing of pharmaceutical specialties and surgical and medical devices. Cutting-edge innovation, continuous development, a clear understanding of patients and caregivers needs, have shaped an extensive spectrum of eye care products, developed and marketed by our main Italian and foreign branches.
Since June 2015 SIFI is backed by 21 Investimenti, private equity firm founded by Alessandro Benetton to support the company’s international expansion and portfolio development strategy.

S.I.F.I. S.P.A.
Focused on development, production and marketing of pharmaceutical specialties, nutraceuticals and ophthalmic cosmetics, S.I.F.I. S.p.A. is present in 13 countries with a portfolio of over 50 pharmaceutical products. Sifi’s pharmaceutical selection provides treatment options to respond to and treat diverse eyecare conditions. Our portfolio includes steroids, anti-inflammatories, anti-glaucoma, anti-infectives, antibiotics-anti-inflammatory associations, allergy treatments, food supplements (nutraceuticals), artificial tears and re-epithelizing drugs.

SIFI MEDTECH focuses on developing, producing and marketing superior quality surgical and diagnostic products. Specialized in ophthalmology, it provides advanced solutions for cataract surgery and presbyopia with a portfolio including intraocular lens, advanced viscoelastics, surgical disposables , imagery diagnostic instruments and vision testers.

Eyelab is a young and smart pharmaceutical company affiliated to SIFI Group. It was created in 2008 to offer direct distribution of various products developed in SIFI’s 80-year long commitment to treat ophthalmic diseases.

Created in 1998 Oftafarma successfully markets SIFI products in the Romanian market, one of the most dynamic in Eastern Europe, with a focus on innovation in ophthalmology.

Founded in 2007, SIFI’s Central American Laboratories mark the beginning of SIFI Group penetration into one of the most promising emerging markets.

share & tag us with
#history #EyeCare #eyeinfo #health #innovation #business #eye #vision #leadership #pharma
“Vision is the art of seeing what is invisible to others.”
Jonathan Swift

Quality We CARE for patients; all patients, even those frequently left behind by the industry, such as individuals afflicted by rare diseases.   SIFI’s 80-year long history is distinguished...
SIFI Group has a Vigilance system that allows us to take full responsibility for our medical and non medical products, both marketed or in clinical development and to take appropriate...
Disclosure of Transfers of value    SIFI is a pharmaceutical company committed to fulfilling the needs of its customers, both patients and ophthalmologists.   SIFI strongly...

On our Social Channels

From our News Center

MINI WELL READY, an innovative lens for the surgical correction of presbyopia has been registered and approved by the South Korean Ministry of Food & Drug Safety.   SIFI, Italian leader...


12 July

ATLANTA, July 12, 2017 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (NASDAQ:ALIM) (Alimera), a leader in the commercialization, research, and development of prescription ophthalmic...
Follow Us!